• LLY-507: A Potent SMYD2 Inhibitor for Cancer and Fibrosis Re

  2026-05-04

  LLY507, a highly selective SMYD2 inhibitor from APExBIO, empowers researchers to dissect epigenetic mechanisms in cancer and renal fibrosis with precision. This article details evidence-backed workflows, advanced applications, and troubleshooting insights to maximize LLY507’s impact in translational and preclinical studies.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-05-04

  This study uncovers that certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by stabilizing a phosphatase-accessible conformation. These insights expand mechanistic understanding of kinase regulation and offer new avenues to achieve specificity in inflammatory and cytokine inhibition research.

• GANT61 in Tumor Immune Evasion: Beyond Canonical GLI Inhibit

  2026-05-03

  Explore how GANT61, a potent GLI inhibitor, is redefining cancer research by targeting tumor immune evasion mechanisms. This in-depth analysis reveals new insights tying Hedgehog pathway blockade to immunotherapy resistance, setting this article apart from existing workflow guides.

• Applied Use of BPN-19186 in sEH-Nrf2 Signaling Pathway Modul

  2026-05-02

  BPN-19186 ((S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea) enables robust, reproducible modulation of the sEH-Nrf2 axis in biochemical and disease-model assays. Its high purity and solubility profile empower advanced signaling pathway and enzyme inhibition studies, with protocol refinements that streamline troubleshooting and maximize assay fidelity.

• Multiomics Dissection of Crossbreeding Effects in Xingguo Ge

  2026-05-02

  This study employs integrated transcriptomic and metabolomic analyses to reveal how crossbreeding and sex influence growth, slaughter performance, and meat quality in Xingguo gray geese. The findings highlight regulatory networks affecting muscle development and lipid metabolism, providing a molecular basis for improving goose production traits.

• A Drug-Sensitized Yeast Platform for mTOR Inhibitor Discover

  2026-05-01

  This study introduces a highly sensitive yeast-based screening system for identifying mTOR inhibitors, enhancing detection by over 200-fold compared to wild-type strains. The platform enables rapid, cost-effective discovery of TOR pathway modulators and clarifies compound selectivity, with implications for geroprotective and anti-cancer research.

• Paclitaxel (Taxol) in Cancer Research: Protocols & Innovatio

  2026-04-30

  Paclitaxel (Taxol) remains the gold standard for modeling cell cycle arrest and apoptosis in oncology research, enabling robust preclinical workflows. Here, we detail cutting-edge experimental strategies, protocol enhancements, and troubleshooting guidance to maximize its application in breast and ovarian cancer models.

• Dihydroethidium (DHE): Next-Gen Redox Assays via Nrf2-GPX4 A

  2026-04-30

  Explore how Dihydroethidium (DHE) empowers advanced intracellular reactive oxygen species measurement by leveraging insights from the Nrf2/GPX4 antioxidant axis. This article delivers a unique, application-focused guide for researchers in oxidative stress and ferroptosis.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Apoptosis Re

  2026-04-29

  Q-VD(OMe)-OPh, a potent pan-caspase inhibitor from APExBIO, empowers researchers to dissect apoptotic pathways with extraordinary specificity and low toxicity. Its robust performance in apoptosis assays, cancer differentiation protocols, and neuroprotection studies positions it as an essential tool for translational breakthroughs in cell death research.

• Temafloxacin: Enhancing Fluoroquinolone Antibacterial Assays

  2026-04-29

  Temafloxacin stands out as a fluoroquinolone broad-spectrum antibacterial agent with proven efficacy against both Gram-positive and Gram-negative bacteria, as well as intracellular pathogens. This guide delivers actionable workflows, troubleshooting tips, and comparative insights to optimize advanced antibacterial and intracellular bactericidal assays for research applications.

• SAR Probing of KX2-391 Analogues: New Insights into Kinase S

  2026-04-28

  Omar et al.'s study systematically explores how structural modifications of KX2-391 dihydrochloride analogues affect their inhibition profiles across major oncogenic kinases. Their findings reveal that scaffold-hopping can dramatically shift selectivity and cytotoxic mechanisms, with implications for designing novel multi-kinase inhibitors in leukemia and beyond.

• Unraveling Complete Nicotine Biosynthesis in Plants

  2026-04-28

  Chang et al. (2026) elucidate the full biosynthetic pathway of nicotine in Nicotiana species, revealing the assembly of a vacuolar five-enzyme metabolon and critical glycosylation steps. This work provides a foundation for metabolic engineering of nicotine production and advances understanding of alkaloid scaffold formation.

• Pifithrin-α (PFTα): Precision p53 Inhibition in Apoptosis Re

  2026-04-27

  Pifithrin-α is a synthetic p53 inhibitor widely used to study p53-dependent apoptosis, cell cycle arrest, and ferroptosis. This article details its mechanism, key evidence, and practical limitations. APExBIO’s A4206 formulation ensures reliable experimental performance.

• Dual-Action Inhibitors Accelerate p38α MAPK Dephosphorylatio

  2026-04-27

  This study demonstrates that certain kinase inhibitors, beyond blocking p38α MAPK activity, also promote its dephosphorylation by stabilizing an activation loop conformation accessible to phosphatases. These findings offer a mechanistic framework for designing more potent, specific kinase inhibitors and expand our understanding of kinase-phosphatase interplay.

• SB 431542 (SKU A8249): Reliable ALK5 Inhibitor for TGF-β Ass

  2026-04-26

  This scenario-driven article examines how SB 431542 (SKU A8249) addresses reproducibility, sensitivity, and workflow optimization in TGF-β signaling assays. Drawing on peer-reviewed data and real laboratory challenges, it guides researchers in choosing, applying, and interpreting results with SB 431542 for robust cell viability and immunology studies.

401 records 16/27 page Previous Next First page 上5页 1617181920 下5页 Last page